Literature DB >> 29724417

ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.

Adam T Froemming1, Sadhna Verma2, Steven C Eberhardt3, Aytekin Oto4, Lauren F Alexander5, Brian C Allen6, Fergus V Coakley7, Brian J Davis8, Pat F Fulgham9, Keyanoosh Hosseinzadeh10, Christopher Porter11, V Anik Sahni12, David M Schuster13, Timothy N Showalter14, Aradhana M Venkatesan15, Carolyn L Wang16, Erick M Remer17.   

Abstract

Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men with recurrent prostate cancer are rapidly evolving, particularly with PET and MRI. At the same time, treatment options and capabilities are expanding and improving. These recommendations separate patients into three broad categories: (1) patients status post-radical prostatectomy, (2) clinical concern for residual or recurrent disease after nonsurgical local and pelvic treatments, and (3) metastatic prostate. This article is a review of the current literature regarding imaging in these settings and the resulting recommendations for imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2018 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Appropriate Use Criteria; Appropriateness Criteria; Choline and fluciclovine PET; MRI; Metastatic prostate cancer; Prostate cancer; Recurrent prostate cancer

Mesh:

Substances:

Year:  2018        PMID: 29724417     DOI: 10.1016/j.jacr.2018.03.019

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  5 in total

1.  Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy.

Authors:  Nicola J Nasser; Victoria Chernyak; Viswanathan Shankar; Madhur Garg; William Bodner; Shalom Kalnicki; Jonathan Klein
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

2.  Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy.

Authors:  Lino M Sawicki; Julian Kirchner; Carolin Buddensieck; Christina Antke; Tim Ullrich; Lars Schimmöller; Johannes Boos; Christoph Schleich; Benedikt M Schaarschmidt; Christian Buchbender; Philipp Heusch; Robert Rabenalt; Peter Albers; Gerald Antoch; Hans-Wilhelm Müller; Hubertus Hautzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-16       Impact factor: 9.236

Review 3.  The role of MRI in prostate cancer: current and future directions.

Authors:  Maria Clara Fernandes; Onur Yildirim; Sungmin Woo; Hebert Alberto Vargas; Hedvig Hricak
Journal:  MAGMA       Date:  2022-03-16       Impact factor: 2.533

4.  Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.

Authors:  Hossein Jadvar; Jeremie Calais; Stefano Fanti; Felix Feng; Kirsten L Greene; James L Gulley; Michael Hofman; Bridget F Koontz; Daniel W Lin; Michael J Morris; Steve P Rowe; Trevor J Royce; Simpa Salami; Bital Savir-Baruch; Sandy Srinivas; Thomas A Hope
Journal:  J Nucl Med       Date:  2021-09-30       Impact factor: 11.082

5.  Clinical Application of the New Prostate Imaging for Recurrence Reporting (PI-RR) Score Proposed to Evaluate the Local Recurrence of Prostate Cancer after Radical Prostatectomy.

Authors:  Federica Ciccarese; Beniamino Corcioni; Lorenzo Bianchi; Antonio De Cinque; Alexandro Paccapelo; Giovanni Luca Galletta; Riccardo Schiavina; Eugenio Brunocilla; Rita Golfieri; Caterina Gaudiano
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.